Naproxen Sodium for the Treatment of OCD in Children With PANDAS

Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS

New clinical trial on the use of Aleve for symptoms of OCD in PANDAS patients. Kyle Williams, MD from MGH is the lead investigator on this double-blind, randomized, placebo-controlled trial. Details on eligibility are on the Clinical Trials website.
This project aims to rigorously evaluate a potential treatment for inflammation-related Obsessive-Compulsive Disorder (OCD) symptoms in children. To accomplish this goal, the investigators will conduct a double-blind, randomized, placebo-controlled trial of Naproxen Sodium, a nonsteroidal anti-inflammatory drug (NSAID) in participants diagnosed with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal infections (PANDAS). This research fills a gap in the empirical evidence base for the treatment of PANDAS, and will add to a growing literature of empirically-derived practices for PANDAS.
Clinical Trial Information for more information on study eligibility and criteria.

Leave a comment